mecImpactReport 2022 v1.7 lr pages - Flipbook - Page 3
3
Robert Dufton
Chief executive
Moorfields Eye Charity
It’s been a year in which Covid-19 continued to present challenges
and when new digital innovations were embedded in service
delivery. There’s also been a renewed focus on research and the
opportunities ahead. We’re proud to fund Moorfields and UCL:
supporting NHS staff to provide better patient care and researchers
to discover new treatments and cures, and jointly helping prepare
for the future demands of eye health globally with Oriel.
This impact report represents our work in the
financial year to 31 March 2022. Over the last
year, we’ve awarded over £6 million in grants
to support innovation in research, care and
education at Moorfields and UCL.
It was a year of major Oriel milestones with
more philanthropic commitments, submission
of the Moorfields’ Full Business Case to
HM Treasury for approval, and exchange
of conditional contracts with the preferred
developer of the Moorfields and UCL sites.
Thanks to your support we’ve seen advances in
research we’re funding including into inherited
eye diseases and use of AI in eye health. We’ve
also seen the benefits to patients’ wellbeing
with our support of the counselling service,
giving children and their families emotional help.
We continue to fund researchers at different
stages of their careers and we’re very proud
that many receive prizes which further raise
the profile of their work.
Along with other members, we endorsed the
Association of Medical Research Charities’
#ResearchAtRisk campaign. This has led to
the government starting to provide additional
support to research charities.
Thank you to everyone who supports us –
it makes a huge difference to the work of
researchers and clinicians, and to the lives of
patients in the UK and globally.